A current trend in dialysis membrane engineering is to maximize the permeability for larger low-molecular weight proteins while retaining albumin. Protein-leaking dialysis membranes do not meet these requirements. Particularly in convective procedures, such as hemodiafiltration, their albumin leakage is too high \[10\]. POLYNEPHRON™, the membrane which is built in to the new Nipro ELISIO® dialyzer, is a new dialysis membrane, produced by applying an innovative spinning technique. The incentive of its development was to improve the characteristics of existing dialysis membranes, i.e., realizing a steeper sieving profile for low-molecular weight proteins without significant loss of essential larger proteins at best biocompatibility properties, for a more adequate dialysis therapy. Purpose of the planned study is to demonstrate the superior performance at lower albumin loss in different dialysis procedures of the new Nipro ELISIO® dialyzer compared with a control dialyzer with regard to the removal of the whole range of uremic toxins.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
14
one week of three consecutive dialysis treatments, \> 3 hours
one week of three consecutive dialysis treatments, \> 3 hours
University Hospital
Ghent, Belgium
protein-bound toxin removal
Time frame: pre and post dialysis treatment
low-molecular weight protein removal
Time frame: pre and post dialysis treatment
small solute removal
Time frame: pre and post dialysis treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.